Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
Gabriele Stengel, Eva Kristina Bee Hautarztpraxis Stengel and Bee, Münster, Germany Abstract: Botulinum toxin type A (BTX-A) preparations are widely used nonsurgical treatments for facial wrinkles. Higher doses of BTX-A are also used for therapeutic purposes in the treatment of conditions...
Main Authors: | Stengel G, Bee EK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-11-01
|
Series: | Clinical Interventions in Aging |
Online Access: | https://www.dovepress.com/antibody-induced-secondary-treatment-failure-in-a-patient-treated-with-peer-reviewed-article-CIA |
Similar Items
-
Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
by: Joely Kaufman-Janette, et al.
Published: (2021-07-01) -
Botulinum toxin type-A in the treatment of glabellar lines
by: Leslie Winter, et al.
Published: (2009-12-01) -
OnabotulinumtoxinA Injection for Glabellar Frown Lines as an Adjunctive Treatment for Depression
by: Witbooi, Inga Robyn
Published: (2018) -
Botulinum toxin type A for the management of glabellar rhytids
by: Anne Marie Tremaine, et al.
Published: (2010-04-01) -
Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines
by: Prager W
Published: (2013-03-01)